Materialise hosts 8th 3D Printing in Hospitals Forum, highlights 3D planning as underrated surgical tool

Materialise held the 8th edition of its 3D Printing in Hospitals Forum, where EVP of Medical Koen Peters opened with the case of Aaron James, a patient who received a full face and eye transplant using Materialise’s 3D-printed surgical cutting guides. Peters framed the story not as a sustainable model but as proof of concept, arguing that the real value lies in preoperative 3D planning—a step that remains undervalued by reimbursement systems. The forum gathered hospital administrators, surgeons, and regulators to discuss how to move from miracle cases to scalable clinical workflows.

The significance of this forum lies in its focus on the software and planning layer rather than the printed implant itself. In the medical-dental vertical, the hardware race—between LPBF, binder jetting, and vat photopolymerization—has dominated headlines, but Materialise is betting that the bottleneck is now upstream: DfAM for surgical simulation, patient-specific cutting guides, and regulatory documentation. This aligns with the broader industry pattern where software and service revenue (6% of the $24.2B broad AM market) often drives higher margins and stickier customer relationships than hardware sales. Competitors like 3D Systems and Stryker offer similar planning tools, but Materialise’s hospital-facing forum format directly targets the reimbursement and workflow adoption gap that has kept 3D planning from becoming standard of care.

From an expert standpoint, the forum’s emphasis on reimbursement language is the most concrete signal here. Peters explicitly noted that authorities speak “the language of numbers,” meaning Materialise must now deliver cost-effectiveness studies that prove 3D planning reduces operating room time, complication rates, or revision surgeries. Without that data, even the most compelling surgical success stories will remain isolated cases rather than embedded clinical practice. The company’s next execution step is to convert forum discussions into published health-economic evidence that can sway payers and hospital procurement committees.